Elevance Health(ELV)

搜索文档
Elevance Health(ELV) - 2021 Q3 - Earnings Call Transcript
2021-10-21 01:27
Anthem, Inc. (ANTM) Q3 2021 Earnings Conference Call October 20, 2021 8:30 AM ET Company Participants Stephen Tanal – CFA, VP, IR Gail Boudreaux – President, CEO John Gallina – Executive VP, CFO Peter Haytaian – President of our Diversified Business Group Morgan Kendrick – President of our Commercial and Specialty Business Division Felicia Norwood – President of our Government Business Division Conference Call Participants A.J. Rice – Credit Suisse Justin Lake – Wolfe Research Lance Wilkes – Bernstein Matt ...
Elevance Health(ELV) - 2021 Q3 - Quarterly Report
2021-10-20 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ANTHEM, INC. (Exact name of registrant as specified in its charter) Indiana 35-2145715 (State or other jurisdiction o ...
Elevance Health(ELV) - 2021 Q2 - Earnings Call Transcript
2021-07-22 03:38
Anthem, Inc. (ANTM) Q2 2021 Earnings Conference Call July 21, 2021 8:30 AM ET Company Participants Stephen Tanal - Vice President of Investor Relations Gail Boudreaux - President and Chief Executive Officer John Gallina - Executive Vice President and Chief Financial Officer Felicia Norwood - Executive Vice President and President, Government Business Division Peter Haytaian - Executive Vice President and President, Commercial and Specialty Business Division Jeff Alter - Executive Vice President IngenioRx a ...
Elevance Health(ELV) - 2021 Q2 - Quarterly Report
2021-07-21 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ANTHEM, INC. (Exact name of registrant as specified in its charter) Indiana 35-2145715 (State or other jurisdiction of inc ...
Elevance Health(ELV) - 2021 Q1 - Earnings Call Transcript
2021-04-21 23:43
Anthem, Inc. (ANTM) Q1 2021 Earnings Conference Call April 21, 2021 8:30 AM ET Company Participants Steve Tanal - Vice President, Investor Relations Gail Boudreaux - President and Chief Executive Officer John Gallina - Chief Financial Officer Felicia Norwood - President, Government Business Division Pete Haytaian - President, Commercial and Specialty Business Division Conference Call Participants Justin Lake - Wolfe Research Matt Borsch - BMO Capital Markets A.J. Rice - Credit Suisse Lance Wilkes - Bernstei ...
Elevance Health(ELV) - 2021 Q1 - Quarterly Report
2021-04-21 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange For the Quarterly Period Ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file ...
Elevance Health(ELV) - 2020 Q4 - Annual Report
2021-02-18 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ANTHEM, INC. (Exact name of registrant as specified in its charter) Indiana 35-2145715 (State or other jurisdiction of incorpo ...
Elevance Health(ELV) - 2020 Q4 - Earnings Call Transcript
2021-01-28 05:24
Anthem, Inc. (ANTM) Q4 2020 Earnings Conference Call January 27, 2021 8:30 AM ET Company Participants Chris Rigg – Vice President-Investor Relations Gail Boudreaux – President and Chief Executive Officer John Gallina – Chief Financial Officer Pete Haytaian – President-Commercial and Specialty Business Division Felicia Norwood – President-Government Business Division Conference Call Participants Justin Lake – Wolfe Research A.J. Rice – Credit Suisse Steven Valiquette – Barclays Ricky Goldwasser – Morgan Stan ...
Elevance Health(ELV) - 2020 Q3 - Quarterly Report
2020-10-29 04:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange For the Quarterly Period Ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission f ...
Elevance Health(ELV) - 2020 Q3 - Earnings Call Transcript
2020-10-29 03:25
Anthem, Inc. (ANTM) Q3 2020 Earnings Conference Call October 28, 2020 8:30 AM ET Company Participants Chris Rigg - Vice President, Investor Relations Gail Boudreaux - President and Chief Executive Officer John Gallina - Chief Financial Officer Felicia Norwood - President of Government Business Division Pete Haytaian - President of Commercial and Specialty Business Division Conference Call Participants Stephen Valiquette - Barclays A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Ricky Goldwasser - Mor ...